ClinicalTrials.gg
CompletedNCT03469869Updated Feb 25, 2019

Effects of Balanced and Sustainable Diet Application for Insulin Resistance and Inflammation Marker of Obese People

An interventional study of balanced and sustainable diet in Obesity, Insulin Resistance and Inflammation, sponsored by Indonesia University. Completed at 1 site in Indonesia. Open to female participants aged 19 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-25.

Sponsored by Indonesia University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years to 59 Years
Sex
Female
01

Study summary

This study evaluates the effect of balanced and sustainable diet application on fat composition, insulin resistance and inflammation marker in obese people.

Intervention: Obese subject will receive intervention on balanced and sustainable diet application Control: Obese subject will receive a balanced diet application only

Read the detailed description

Maintaining the adherence of weight loss programme while selecting healthy and sustainable foods will become a worldwide future challenge in nutrition. Therefore, we investigated the suitable content, graphic, and flow in developing a mobile application as an alternative solution for enhancing the compliance of weight control and selecting healthy food with the least environmental impact.

The treatment for obesity consists of dieting, physical exercise, pharmacology, and surgery. Restricted balanced diet is a well known diet recommendation for people with obesity. Sustainable diet is an alternative form of diet which contributes to healthy life and is protective of biodiversity.

The main challenge in obesity management is the sustainability of weight loss programme. Mobile apps are an alternative solution for enhancing compliance.

02

Conditions studied

  • Obesity
  • Insulin Resistance
  • Inflammation
  • Blood Glucose, High

Keywords

  • Obesity
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's enrollment of 60 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Indonesia University is the lead sponsor of 446 studies on the registry; 56 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 59 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 25 kg/m2
  • using Android-based smartphone
  • willing to join this research by signing

Exclusion criteria

Exclusion Criteria:

  • pale in physical examination
  • in weight loss program
  • have obesity with comorbidities
  • have hormonal diseases
  • consumed hormonal drug, PTU, anti diabetes drug
  • smoking or stop smoking under 2 years
  • pregnant and breastfeeding women
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    balanced and sustainable diet

    The intervention group will receive menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the control group will receive menu recommendation of balanced diet for 8 weeks. these menus are given in the apps

    Other: balanced and sustainable diet

  • Active comparator
    balanced diet

    the intervention group receive get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the other group will receive menu recommendation of balanced diet for 8 weeks. these menus are given in the apps

    Other: balanced and sustainable diet

Interventions

  • Otherbalanced and sustainable diet

    the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp. the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp.

06

What researchers measure

Primary outcomes

  1. Change of body weight

    Change from baseline body weight at 8 weeks, is measured in kg

    Time frame: baseline at Day0 and endline at Day56

Secondary outcomes

  1. Change of Fat Mass

    Change from baseline Fat Mass at 8 weeks, is measured by body composition analyzer in kg

    Time frame: baseline at Day0 and endline at Day56

  2. Change of Fasting plasma glucose

    Change from baseline Fasting plasma glucose at 8 weeks, is measured in mg/dL

    Time frame: baseline at Day0 and endline at Day56

  3. Change of TNF alpha

    Change from baseline TNF alpha at 8 weeks, is measured in pg/ml

    Time frame: baseline at Day0 and endline at Day56

  4. Change of Fasting Insulin

    Change from baseline Fasting Insulin at 8 weeks, is measured in µU/mL

    Time frame: baseline at Day0 and endline at Day56

  5. Change of HOMA-IR

    Change from baseline HOMA-IR at 8 weeks, is measured using formulation : glukosa (mg/dL) x insulin (µU/mL)/405

    Time frame: baseline at Day0 and endline at Day56

  6. Change of Waist Circumference

    Change from baseline Waist Circumference at 8 weeks, is measured in cm

    Time frame: baseline at Day0 and endline at Day56

  7. Change of Carbohydrate intake

    Change from baseline Carbohydrate intake at 8 weeks, is measured in gram using 24HR-recall

    Time frame: baseline at Day0 and endline at Day56

  8. Change of Fat intake

    Change from baseline Fat intake at 8 weeks, is measured in gram using 24HR-recall

    Time frame: baseline at Day0 and endline at Day56

  9. Change of Protein intake

    Change from baseline Protein intake at 8 weeks, is measured in gram using 24HR-recall

    Time frame: baseline at Day0 and endline at Day56

07

Study locations

1 site
  • University of Indonesia
    Depok, West Java 16424, Indonesia
08

References and documents

Publications

  • Agustina R, Febriyanti E, Putri M, Martineta M, Hardiany NS, Mustikawati DE, Hanifa H, Shankar AH. Development and preliminary validity of an Indonesian mobile application for a balanced and sustainable diet for obesity management. BMC Public Health. 2022 Jun 20;22(1):1221. doi: 10.1186/s12889-022-13579-x. PubMed 35725407 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03469869
Collaborators
Fakultas Kedokteran Universitas Indonesia
Responsible party
Rina Agustina (Head of Human Nutrition Research Center, Indonesia University) — Principal investigator
First posted
Mar 19, 2018
Start date
Mar 16, 2018
Primary completion
Jun 30, 2018
Completion
Oct 31, 2018
Last update
Feb 25, 2019

Study contacts

Rina Agustina, PhD
principal investigator · Indonesia University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion